4.8 Article

Differential Biodistribution of Adenoviral-Vectored Vaccine Following Intranasal and Endotracheal Deliveries Leads to Different Immune Outcomes

期刊

FRONTIERS IN IMMUNOLOGY
卷 13, 期 -, 页码 -

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2022.860399

关键词

respiratory mucosal immunization; intranasal; endotracheal; biodistribution; Adenovirus-vectored vaccine; Tuberculosis; mucosal immunity; T cells

向作者/读者索取更多资源

Infectious diseases of the respiratory tract are a major cause of global morbidity and mortality. Delivering vaccines through the respiratory mucosal route shows promise in combating respiratory infections. Through a study using mice, we found that compared to intranasal delivery, endotracheal delivery resulted in a deeper and wider distribution of the vaccine in the lungs, leading to improved immunogenicity and protection against the target pathogen. Our findings support the further development of inhaled aerosol delivery of vaccines over intranasal delivery for human use.
Infectious diseases of the respiratory tract are one of the top causes of global morbidity and mortality with lower respiratory tract infections being the fourth leading cause of death. The respiratory mucosal (RM) route of vaccine delivery represents a promising strategy against respiratory infections. Although both intranasal and inhaled aerosol methods have been established for human application, there is a considerable knowledge gap in the relationship of vaccine biodistribution to immune efficacy in the lung. Here, by using a murine model and an adenovirus-vectored model vaccine, we have compared the intranasal and endotracheal delivery methods in their biodistribution, immunogenicity and protective efficacy. We find that compared to intranasal delivery, the deepened and widened biodistribution in the lung following endotracheal delivery is associated with much improved vaccine-mediated immunogenicity and protection against the target pathogen. Our findings thus support further development of inhaled aerosol delivery of vaccines over intranasal delivery for human application.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据